High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
暂无分享,去创建一个
[1] R. Hay,et al. Defective IκBα in Hodgkin cell lines with constitutively active NF-κB , 1998, Oncogene.
[2] C. Mackay,et al. Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.
[3] A. Mantovani,et al. Identification of the CC chemokines TARC and macrophage inflammatory protein‐1β as novel functional ligands for the CCR8 receptor , 1998, European journal of immunology.
[4] M. Baggiolini,et al. CCR5 is characteristic of Th1 lymphocytes , 1998, Nature.
[5] P. Allavena,et al. Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s , 1998, The Journal of experimental medicine.
[6] W. Chan,et al. Clonality in nodular lymphocyte-predominant Hodgkin's disease. , 1997, The New England journal of medicine.
[7] R. Schwartz. Hodgkin's disease--time for a change. , 1997, The New England journal of medicine.
[8] S. Pileri,et al. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. , 1997, The New England journal of medicine.
[9] M. Baggiolini,et al. Identification of CCR8, the Receptor for the Human CC Chemokine I-309* , 1997, The Journal of Biological Chemistry.
[10] O. Yoshie,et al. The T Cell-directed CC Chemokine TARC Is a Highly Specific Biological Ligand for CC Chemokine Receptor 4* , 1997, The Journal of Biological Chemistry.
[11] F. Herrmann,et al. Hodgkin's disease: a tumor with disturbed immunological pathways. , 1997, Immunology today.
[12] G. Pinkus,et al. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation? , 1997, The American journal of pathology.
[13] K. Rajewsky,et al. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells , 1996, The Journal of experimental medicine.
[14] S. Poppema,et al. Immunology of Hodgkin's disease. , 1996, Bailliere's clinical haematology.
[15] O. Yoshie,et al. Molecular Cloning of a Novel T Cell-directed CC Chemokine Expressed in Thymus by Signal Sequence Trap Using Epstein-Barr Virus Vector* , 1996, The Journal of Biological Chemistry.
[16] B. Dörken,et al. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. , 1996, Blood.
[17] V. Diehl,et al. Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed-Sternberg cells of a Hodgkin's lymphoma patient. , 1996, Blood.
[18] O. Yoshie,et al. Constitutive expression of various chemokine genes in human T‐cell lines infected with human T‐cell leukemia virus type 1: Role of the viral transactivator Tax , 1996, International journal of cancer.
[19] H Stein,et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.
[20] S. Poppema. The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease. , 1989, The American journal of pathology.
[21] P. Sherrington,et al. A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene , 1988 .
[22] S. Poppema,et al. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[23] V. Diehl,et al. Characteristics of Hodgkin's disease-derived cell lines. , 1982, Cancer treatment reports.
[24] S. Poppema,et al. CD45 (leucocyte common antigen) expression in T and B lymphocyte subsets. , 1996, Leukemia & lymphoma.